KTRA · Categories · Form 4

KTRA - SEC Form 4 insider transactions

Kintara Therapeutics Inc. (KTRA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for KTRA

• 590d
  SEC Form 4 filed by Chief Scientific Officer Yamashita Dennis

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 590d
  SEC Form 4 filed by Director Ng George K

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 590d
  SEC Form 4 filed by Director List Alan

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 590d
  SEC Form 4 filed by Director Manuso James S J

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 590d
  Chief Executive Officer Bianco James A. was granted 2,323,307 shares (SEC Form 4)

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 590d
  SEC Form 4 filed by Chief Financial Officer Dearborn Dan

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1007d
  SEC Form 4 filed by Johnson Laura L.

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1007d
  SEC Form 4 filed by Favorito Tamara A

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1007d
  SEC Form 4 filed by Hoffman Robert E.

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1007d
  SEC Form 4 filed by Brown Dennis M

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1007d
  SEC Form 4 filed by Toth Robert Joseph Jr

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1098d
  SEC Form 4 filed by Hoffman Robert E.

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1245d
  SEC Form 4: Brown Dennis M transferred by will 363 shares), increasing direct ownership by 7% to 5,302 units

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1401d
  SEC Form 4: Praill Anthony Scott was granted 240,087 shares, increasing direct ownership by 646% to 277,273 units

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1401d
  SEC Form 4: Hoffman Robert E. was granted 400,145 shares, increasing direct ownership by 728% to 455,145 units

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1401d
  SEC Form 4: Brown Dennis M was granted 240,087 shares, increasing direct ownership by 3,521% to 246,905 units

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1430d
  SEC Form 4 filed by Johnson Laura L.

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1430d
  SEC Form 4 filed by Toth Robert Joseph Jr

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1430d
  SEC Form 4 filed by Seymour Tamara A

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1568d
  SEC Form 4: Hoffman Robert E. bought $25,795 worth of shares (55,000 units at $0.47)

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1638d
  SEC Form 4: Praill Anthony Scott bought $19,430 worth of shares (28,700 units at $0.68), increasing direct ownership by 338% to 37,186 units

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1639d
  SEC Form 4: Zarrabian Saiid bought $31,316 worth of shares (50,000 units at $0.63), increasing direct ownership by 909% to 55,500 units

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1653d
  SEC Form 4: Johnson Laura L. bought $2,227 worth of shares (3,000 units at $0.74)

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1667d
  SEC Form 4 filed by Hoffman Robert

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1716d
  SEC Form 4 filed by Murphy Keith

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1716d
  SEC Form 4 filed by Toth Robert Joseph Jr

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1716d
  SEC Form 4 filed by Seymour Tamara A

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1716d
  SEC Form 4 filed by Hoffman Robert

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1716d
  SEC Form 4 filed by Johnson Laura L.

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1858d
  SEC Form 4 filed by SEYMOUR TAMARA A

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1862d
  SEC Form 4: Brown Dennis M converted 750 units into Common Stock, increasing direct ownership by 12% to 6,818 units

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1862d
  SEC Form 4: Praill Anthony Scott converted 938 units into Common Stock, increasing direct ownership by 13% to 8,486 units

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1862d
  SEC Form 4: TOTH ROBERT JOSEPH JR converted 325 units into Common Stock, increasing direct ownership by 26% to 1,566 units

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1891d
  SEC Form 4: Jr Joseph Robert Toth increased direct ownership by 0.65% to 1,238 units

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1891d
  SEC Form 4: M Dennis Brown increased direct ownership by 0.28% to 6,062 units

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
• 1891d
  SEC Form 4: Scott Anthony Praill increased direct ownership by 0.29% to 7,540 units

  4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)

Other KTRA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends